AGCC vs BEAM

For growth investors, Agencia Comercial Spirits Ltd (AGCC) is the stronger pick with 186.

0% revenue growth year-over-year, versus 120. 0% for Beam Therapeutics Inc. (BEAM). Analysts rate Beam Therapeutics Inc. (BEAM) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Agencia Comercial Spirits Ltd (AGCC) delivered a total return of +207.

4%, compared to -55. 6% for Beam Therapeutics Inc. (BEAM). Over 10 years, the gap is even starker: AGCC returned +207. 4% versus BEAM's +67. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Agencia Comercial Spirits Ltd (AGCC) is the lower-risk stock at 1.

68β versus Beam Therapeutics Inc. 's 2. 14β — meaning BEAM is approximately 28% more volatile than AGCC relative to the S&P 500. On balance sheet safety, Agencia Comercial Spirits Ltd (AGCC) carries a lower debt/equity ratio of 7% versus 24% for Beam Therapeutics Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Agencia Comercial Spirits Ltd (AGCC) is pulling ahead at 186.

0% versus 120. 0% for Beam Therapeutics Inc. (BEAM). Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Agencia Comercial Spirits Ltd (AGCC) is the more profitable company, earning 30.

7% net margin versus -57. 2% for Beam Therapeutics Inc. — meaning it keeps 30. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AGCC leads at 40. 0% versus -274. 6% for BEAM. At the gross margin level — before operating expenses — BEAM leads at 84. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Agencia Comercial Spirits Ltd (AGCC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+207.

4% 10Y return). Beam Therapeutics Inc. (BEAM) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AGCC: +207. 4%, BEAM: +67. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AGCC (Consumer Defensive) and BEAM (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.